Illumina's Stock Climbs 29 Percent on Strong Q2 Revenue Growth, Profit
Jul 19, 2006
NEW YORK (GenomeWeb News) - Shares in Illumina were up more than 29 percent, or $8.42, at $37.28 in mid-afternoon trading after the company reported strong second-quarter earnings.
As GenomeWeb News reported this morning, Illumina reported a 163-percent surge in second-quarter revenues and swung into profitability from a loss in the second quarter of 2005.
Separately today, research firm Global Crown Capital upgraded Illumina's stock to "Overweight" from "Neutral."